Simeen Pasha
Pediatric Endocrinology · Jackson, MSNPI 1821275405
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.7% of the total across 81 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 15.3% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $415, 2.0 times the $204 reported in 2019.
Across 81 payments — averaging $22.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$280
- Novo Nordisk$261
- Dexcom, Inc.$148
- Medtronic$130
- Neurocrine Biosciences, Inc.$107
- Tolmar, Inc.$84
- plus $823 from 19 others
What the payments were for
- Food & beverage$1,75396%
- Education$794%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 14 | $280 |
| Novo Nordisk | 11 | $261 |
| Dexcom, Inc. | 7 | $148 |
| Medtronic | 3 | $130 |
| Neurocrine Biosciences, Inc. | 4 | $107 |
| Tolmar, Inc. | 3 | $84 |
| Kyowa Kirin, Inc. | 4 | $82 |
| Insulet Corporation | 4 | $82 |
| Ultragenyx Pharmaceutical Inc. | 4 | $75 |
| Tandem Diabetes Care, Inc. | 3 | $75 |
| Abbott | 3 | $68 |
| Eton Pharmaceuticals, Inc. | 1 | $67 |
| Tolmar Pharmaceuticals, Inc. | 3 | $64 |
| Pfizer | 3 | $51 |
| Biomarin Pharmaceutical Inc. | 2 | $47 |
| Rhythm Pharmaceuticals, Inc. | 2 | $35 |
| Ascendis Pharma Endocrinology Inc | 1 | $33 |
| Lilly USA, LLC | 2 | $25 |
| Xeris Pharmaceuticals, Inc. | 1 | $24 |
| BD | 1 | $22 |
| Ferring Pharmaceuticals Inc. | 1 | $19 |
| Azurity Pharmaceuticals, Inc. | 1 | $19 |
| Arbor Pharmaceuticals, Inc. | 1 | $15 |
| AstraZeneca | 1 | $13 |
| BETA Bionics, Inc. | 1 | $6 |
How this compares
Too few pediatric endocrinology providers in Mississippito place this figure against a meaningful peer group, so we don't.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Levothyroxine Sodium | 23 | $69 |
Paid to pharmacies, not to this prescriber.
Other pediatric endocrinology in Jackson
- Naznin DixitJackson$7K
- Anju SukumaranJackson$2K
- Namrata KotwalJackson$945
- Obiageli ObiJackson$679
- George MollJackson$35
- Jessica LilleyTupelo$18K
- Sara SilverTupelo$1K
- Amy PotterMadison$835
- Saima HanifMadison$46
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.